Beneficient Enters into New GP Primary Capital Transaction

Rhea-AI Summary

Beneficient (NASDAQ: BENF) has announced the closure of a $233,333 primary capital commitment for Cork & Vines Fund I, LP, marking its second GP Primary transaction of the fiscal year. The Fund received Resettable Convertible Preferred Stock convertible into BENF Class A common stock.

This transaction represents Ben's third deal since launching the program in late 2024, expected to increase the collateral for the Company's ExAlt loan portfolio by approximately $233,333. The company also entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions.

Upon closing of the Public Stockholder Enhancement Transactions, this deal is anticipated to add approximately $77,777 to the tangible book value attributable to stockholders. The GP Primary Commitment Program aims to address up to $330 billion of potential demand for primary commitments in fundraising needs.

Positive

• New $233,333 primary capital commitment secured
• Expansion of ExAlt loan portfolio collateral by $233,333
• Expected addition of $77,777 to tangible book value
• Third successful GP Primary transaction since program launch

Negative

• Low market capitalization of only $2.21 million as of April 24, 2025

Insights

Financial Analyst

Beneficient closed a $233,333 primary capital transaction that adds collateral and increases tangible book value attributable to stockholders by $77,777.

Beneficient has completed a $233,333 primary capital commitment transaction with Cork & Vines Fund I, LP, representing their second GP Primary transaction this fiscal year and third since formally launching the program in late 2024. The structure involves Beneficient providing Resettable Convertible Preferred Stock in exchange for an interest in the fund, which focuses on premium experiential luxury dining investments.

The financial impact is twofold: First, it increases the collateral for the company's ExAlt loan portfolio by approximately $233,333. Second, upon closing of the previously announced Public Stockholder Enhancement Transactions, this transaction will add approximately $77,777 of tangible book value attributable to stockholders.

The financial tables reveal an important structural shift occurring: As of December 31, 2024, while Beneficient had $91,772,000 in total tangible book value, the tangible book value attributable to public company stockholders was $0. After the Public Stockholder Enhancement Transactions and including this and a previous GP Primary transaction, that figure is projected to reach $10,535,000.

This transaction represents continued execution of Beneficient's GP Primary Commitment Program strategy, which aims to provide primary capital solutions to general partners during fundraising efforts. The company positions this program as addressing potential market demand of up to $330 billion for primary commitments.

For context, the current market capitalization of Beneficient's Class A and Class B common stock stands at just $2,211,000 as of April 24, 2025, significantly below the company's stated tangible book value. This transaction, while modest in size, continues the company's efforts to execute on its stated liquidity and primary capital strategy.

DALLAS, April 25, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced it has closed on the financing of a $233,333 primary capital commitment for Cork & Vines Fund I, LP (“Fund”), a fund managed by Cork & Vines GP, LP, an asset manager investing in opportunities within the premium experiential, luxury dining segment with a differentiated culinary and strategic wine program focus.

The transaction represents Ben’s second GP Primary transaction of the fiscal year and third since formally launching the program in late 2024. In exchange for an interest in the Fund, the Fund received approximately $233,333 in stated value of shares of the Company’s Resettable Convertible Preferred Stock (the “Preferred Stock”), which is convertible at the election of the holder into shares of the Company’s Class A common stock, subject to the terms and conditions of the transaction documents. As a result of the transaction, the collateral for Company’s ExAlt loan portfolio is expected to increase by approximately $233,333 of interests in alternative assets. Concurrently, the Company also entered into a Preferred Liquidity Provider Program Agreement with the Fund, whereby the Company may facilitate ongoing liquidity solutions for the Fund and its limited partners.

“We are excited to continue the momentum at the outset of this fiscal year by completing another GP primary capital transaction as we work to execute on our core liquidity and primary capital strategy,” said Beneficient management. “We believe this financing reflects our ability to close transactions that drive shareholder value and enhance the value of the collateral backing our ExAlt loan portfolio. We will continue to pursue additional opportunities that align with our strategic vision and growth objectives.”

Upon closing of the previously announced Public Stockholder Enhancement Transactions (the “Transactions”), the Company believes this transaction will result in the addition of approximately $77,777 (and an aggregate of approximately $10.54 million) of tangible book value attributable to the Company’s stockholders.

Beneficient’s GP Primary Commitment Program is focused on providing primary capital solutions and financing anchor commitments to general partners during their fundraising efforts while immediately deploying capital into our equity. Through the program, Beneficient seeks to help satisfy the up to $330 billion of potential demand for primary commitments to meet fundraising needs.

Reconciliation of Non-GAAP Financial Measures
The following tables reconciles these non-GAAP financial measures to the most comparable GAAP financial measures as of December 31, 2024, on an actual basis and pro forma assuming the Transactions occurred on December 31, 2024.
(dollars in thousands)		Actual				Pro forma – Transactions (1)			Pro forma - Transactions and GP Primary (3)
Tangible Book Value
Total equity (deficit)			14,260			14,260			24,093
Less: Goodwill and intangible assets			(13,014	)		(13,014	)		(13,014	)
Plus: Total temporary equity			90,526			90,526			90,526
Tangible book value			91, 772			91,772			101,605
		Actual				Pro forma – Transactions (1)			Pro forma - Transactions and GP Primary (3)
Tangible book value attributable to Ben public company stockholders
Tangible book value			91,772			91,772			101,605
Less: Tangible book value attributable to Beneficient Holdings noncontrolling interest holders			(91,772	)		(82,595	)		(91,070	)
Tangible book value attributable to Ben’s public company stockholders			-			9,177	(2)		10,535	(4)
Market Capitalization of Ben’s Class A and Class B common stock as of April 24, 2025 (5)		$	2,211

(1)  Assumes the Transactions closed on December 31, 2024 including that the Beneficient Holdings limited partnership agreement was amended to provide that Ben, as the indirect holder of the Class A Units and certain Designated Class S Ordinary Units of Beneficient Holdings, would receive in the event of a liquidation of Beneficient Holdings 10% of the first $100 million of distributions of Beneficient Holdings following the satisfaction of the debts and liabilities of Beneficient Holdings on a consolidated basis.
(2)  Pro forma for the Transactions, represents 10% of the first $100 million of distributions of Beneficient Holdings in the event of the liquidation of Beneficient Holdings following the satisfaction of the debts and liabilities Beneficient Holdings on a consolidated basis.
(3)  Assumes the Transactions closed on December 31, 2024 including that the Beneficient Holdings limited partnership agreement was amended to provide that Ben, as the indirect holder of the Class A Units and certain Designated Class S Ordinary Units of Beneficient Holdings, would receive in the event of a liquidation of Beneficient Holdings (i) 10% of the first $100 million of distributions of Beneficient Holdings following the satisfaction of the debts and liabilities of Beneficient Holdings on a consolidated basis and (ii) 33.3333% of the net asset value of the added alternative assets of up to $5 billion in connection with ExAlt Plan liquidity and primary capital transactions entered after December 22, 2024. Pro forma for GP Primary includes the primary capital transaction described herein plus the previously disclosed $9.6 million primary capital commitment for Pulse Pioneer Fund, LP.
(4)  Pro forma for the Transactions, represents (i) 10% of the first $100 million of distributions of Beneficient Holdings in the event of the liquidation of Beneficient Holdings following the satisfaction of the debts and liabilities Beneficient Holdings on a consolidated basis and (ii) 33.3333% of the net asset value of the added alternative assets of up to $5 billion in connection with ExAlt Plan liquidity and primary capital transactions entered after December 22, 2024.
(5)  Based upon the closing price of the Class A common stock as reported by Nasdaq as of market close on April 24, 2025.

About Beneficient 
Beneficient (Nasdaq: BENF) – Ben, for short – is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors − mid-to-high net worth individuals, small-to-midsized institutions and General Partners seeking exit options, anchor commitments and valued-added services for their funds− with solutions that could help them unlock the value in their alternative assets. Ben’s AltQuote® tool provides customers with a range of potential exit options within minutes, while customers can log on to the AltAccess® portal to explore opportunities and receive proposals in a secure online environment.         

Its subsidiary, Beneficient Fiduciary Financial, L.L.C., received its charter under the State of Kansas’ Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight by the Office of the State Bank Commissioner. 

For more information, visit www.trustben.com or follow us on LinkedIn. 

Contacts
Matt Kreps: 214-597-8200, mkreps@darrowir.com
Michael Wetherington: 214-284-1199, mwetherington@darrowir.com
Investor Relations: investors@beneficient.com

Important Information and Where You Can Find It
This press release may be deemed to be solicitation material in respect of a vote of stockholders to approve the Transactions. In connection with the requisite stockholder approval, Ben will file with the Securities and Exchange Commission (the “SEC”) a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of Ben, seeking such approvals related to the Transactions.

INVESTORS AND SECURITY HOLDERS OF BEN AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTIONS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT BEN AND THE TRANSACTIONS. Investors and security holders will be able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about Ben, without charge, at the SEC’s website (http://www.sec.gov). Copies of documents filed with the SEC by Ben can also be obtained, without charge, by directing a request to Investor Relations, Beneficient, 325 North St. Paul Street, Suite 4850, Dallas, Texas 75201, or email investors@beneficient.com.

Participants in the Solicitation of Proxies in Connection with Transactions
Ben and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the requisite stockholder approvals under the rules of the SEC. Information regarding Ben’s directors and executive officers is available in its annual report on Form 10-K for the fiscal year ended March 31, 2024, which was filed with the SEC on July 9, 2024 and certain current reports on Form 8-K filed by Ben. Other information regarding the participants in the solicitation of proxies with respect to the Transactions and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in the preceding paragraph.

Not an Offer of Securities
The information in this communication is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the Transactions have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Forward Looking Statements
Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the Transactions, including receipt of required approvals and satisfaction of other customary closing conditions and excepted timing of closing of the Transactions, and expectations of future plans, strategies, and benefits of the Transactions. The words ”anticipate,” "believe,” ”continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” ”plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by, and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected.

Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among others: the ultimate outcome of the Transactions, including obtaining the requisite vote of securityholders; the Company’s ability to meet expectations regarding the timing and completion of the Transactions; and the risks, uncertainties, and factors set forth under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.  

FAQ

What is the value of Beneficient's (BENF) latest primary capital commitment transaction?

Beneficient's latest primary capital commitment transaction is valued at $233,333 with Cork & Vines Fund I, LP.

How many GP Primary transactions has BENF completed since late 2024?

BENF has completed three GP Primary transactions since formally launching the program in late 2024.

What is the expected impact on BENF's tangible book value from this transaction?

The transaction is expected to add approximately $77,777 to the tangible book value attributable to stockholders upon closing of the Public Stockholder Enhancement Transactions.

What is the market capitalization of BENF's Class A and Class B common stock as of April 24, 2025?

The market capitalization of BENF's Class A and Class B common stock as of April 24, 2025, is $2,211,000.